Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus
Authors:
- 1 December 2016
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 136, 1-8
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG) (FE785/2-2)
This publication has 38 references indexed in Scilit:
- Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocketAntiviral Research, 2015
- Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBPAntiviral Research, 2015
- AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challengesNature, 2015
- Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus InfectionsMolecules, 2011
- Anti-enterovirus activity and structure–activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazolesBiochemical and Biophysical Research Communications, 2006
- Enteroviral Meningitis: Natural History and Outcome of Pleconaril TherapyAntimicrobial Agents and Chemotherapy, 2006
- Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight JunctionsCell, 2006
- Presentation, Diagnosis, and Management of Enterovirus Infections in NeonatesPediatric Drugs, 2004
- Octamerization Enables Soluble CD46 Receptor To Neutralize Measles Virus In Vitro and In VivoJournal of Virology, 2000
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997